Please click button below for an important update regarding access to the AstraZeneca vaccine for patients under 50 years old:
BOOKING INFO: please review before proceeding to book your appointment
Updated 23 April 2021
Phase 2A of the rollout will commence at Double Bay Doctors on 17 May 2021 which means that all Australians aged over 50 years old will now be able to access the AstraZeneca vaccine.
We have temporarily suspended the rollout of AstraZeneca in patients aged under 50 years only. You can read more about this here. We do not currently have information on whether General Practices will be supplied with the Pfizer vaccine.
Please note that you cannot book a standard appointment to receive the COVID-19 vaccine.
The Australian Government is responsible for the COVID-19 vaccine rollout and for providing Double Bay Doctors with COVID-19 vaccine stock each week. At this time there is a shortage of vaccine stock which means eligible patients may not be able to book a vaccine immediately.
To manage the vaccine shortage, we have created a Reservation List to manage vaccine stock levels and ensure eligible patients can easily book their vaccine when we receive more vaccines.
Once on the Reservation List you will receive an SMS invitation link to book your vaccine appointment as soon as vaccine stock becomes available. You will have 24 hours to book your vaccine appointment after receiving your SMS invitation, before the reserved vaccine is offered to another patient.
Which COVID-19 vaccine will I receive?
Most Australians aged 50 years and older will receive the AstraZeneca vaccine and the Department of Health have advised that other COVID-19 vaccines, such as the Pfizer COVID-19 vaccine, will be made available in Australia for patients aged under 50 years in the months ahead. We do not currently have information on whether General Practices will be supplied with the Pfizer vaccine.
Who can book?
At this stage, you must be an eligible Phase 1B patient over the age of 50 to book a COVID-19 vaccination appointment, or to join the Reservation List for a vaccine, so please confirm you are eligible before attempting to book your appointment, or before joining the Reservation List. Phase 1B patients under the age 50 with eligible medical conditions may book to disucss with their GP if the AstraZenica Covid-19 vaccine is appropriate for them to receive. See here for information on Phase 1B. You will be required to demonstrate your eligibility to access the vaccine under Phase 1B.
Eligible Phase 1B patients who have NOT received a vaccine, including the 2021 Flu Vaccine, within the last 14 days.
You must hold a valid Australian Medicare card.
Non Medicare card holders
If you don't have Medicare you can still access the COVID-19 vaccine free of charge. Non Medicare card holders are required to access the vaccine at a public vaccination site. The closest alternative is the Bondi Junction Respiratory clinic.
COVID-19 Vaccine Reservation List
If you are unable to book a COVID-19 vaccination appointment you will be offered the opportunity to join the Reservation List during the booking process.
When you have joined the Reservation List you will receive an SMS invitation link to book your vaccine appointment as soon as vaccine stock becomes available.
You will have 24 hours to book your vaccine appointment after receiving your SMS invitation, before the reserved vaccine is offered to another patient. If you don't book your appointment within 24 hours, you will need to rejoin the Reservation List. Our reception team will not be able to access or manage the Reservation List, so unfortunately they will not be able to assist you to secure a vaccine.
Please note: Families wishing to reserve vaccines for multiple eligible family members must join the Reservation List individually for each family member.
Who is eligible to access the vaccine under Phase 2A?
All Australians aged over 50 years old. Phase 2A commences in General Practice on 17 May 2021.
Who is eligible to access the vaccine under Phase 1B?
To ensure the most vulnerable in the community are offered protection first, the COVID-19 vaccine will be offered in a phased program to specific groups of the Australian population.
Please note that you will be required to demonstrate your eligibility to access the vaccine under Phase 1B.
If you meet any of the following criteria you fall into the Phase 1B priority group and can receive the AstraZenica COVID-19 vaccine at Double Bay Doctors :
Adults 70 years & over
Other healthcare workers 50 years & older (not included in Phase 1A)
Aboriginal and Torres Strait Islander people ATSI >55 years
Younger adults with an underlying medical conditions, including those with a disability*
Critical & high-risk workers 50 years & older including defense, police, fire, emergency services
*where the benefit of receiving the vaccine outweighs the risks.
You can determine your eligibility for Phase 1B via the following resource:
Detailed information about eligible classes under Phase 1B
Individuals employed in the medical profession, including allied health professionals, aged care and disability workers
All public and private hospital staff
Healthcare workers in private practice
Community pharmacy staff
Healthcare workers providing in-home and community care, including centre-based care
Workforce supporting medical practitioners in a clinical setting, including students on placement
Onsite administrative staff in healthcare settings
Cleaners, kitchen staff and other ancillary staff in healthcare settings
Underlying health conditions
Poorly controlled blood pressure (defined as two or more pharmacologic agents for blood pressure control, regardless of recent readings)
Heart disease - including Ischaemic heart disease, valvular heart disease, cardiomyopathies and pulmonary hypertension
Those with severe mental health conditions - including schizophrenia, bi-polar disorder affecting ability to adhere to public health measures
Chronic inflammatory conditions on medical treatments - including: Systemic Lupus Erythematosus, Rheumatoid Arthritis, Crohn’s disease, ulcerative colitis, and similar who are being treated with Disease modifying anti-rheumatic drugs (DMARDs) or immune-suppressive or immunomodulatory therapies. Generally not inclusive of people living with osteoarthritis, fibromyalgia, myalgic encephalomyelitis/chronic fatigue syndrome or similar non-immunocompromising inflammatory conditions.
Chronic lung disease - including Chronic Obstructive Pulmonary Disease, cystic fibrosis, interstitial lung disease. Does not include mild or moderate asthma
Primary or acquired immunodeficiency - including congenital causes of immunodeficiency and HIV/aids.
Severe obesity with a BMI ≥ 40kg/m2
Solid organ transplant recipients who are on immune suppressive therapy
Adult survivors of childhood cancers
Bone marrow transplant recipients or those on chimeric antigen receptor T-cell (CAR-T) therapy or those on immune suppressive therapy for graft versus host disease
Haematological diseases or cancers including leukaemia, lymphoma or myeloma - diagnosed within the past 5 years or on recently completed active treatment including chemotherapy, radiotherapy, immunotherapy or targeted anti-cancer therapy or with advanced disease regardless of treatment
Non-haematological cancer - diagnosed within the past 5 years or on recently completed active treatment including chemotherapy, radiotherapy, immunotherapy or targeted anti-cancer therapy or with advanced disease regardless of treatment
Primary or acquired immunodeficiency - including congenital causes of immunodeficiency and HIV/AIDS
Chronic renal (kidney) failure with a eGFR of <44mL/min (Does not include mild-moderate chronic kidney disease)
Chronic liver disease
Chronic neurological conditions - including Stroke, dementia, Multiple sclerosis, motor neurone disease, Parkinson’s disease, cerebral palsy. Does not include migraine or cluster headaches.
Those with Down syndrome, muscular dystrophy, traumatic brain and spinal cord injury
Critical and high risk workers
Emergency services personnel, including frontline police officers, fire and rescue personnel, corrective services officers
Rural Fire Service and State Emergency Service volunteers
Active Australian Defence Force personnel
Australian Government officials about to be deployed or currently deployed overseas on official government business
Workers involved in manufacture of AstraZeneca vaccine and distribution/delivery of COVID-19 vaccines
Workers at licensed meat processing businesses (this does not include retail settings, or butchers)
Essential carers (paid and unpaid) including carers who are also family members of someone with disability or an elderly person.
Disability support volunteers who provide support to people in their homes, respite care, educational, employment and leisure settings.
People with a disability attending centre-based services (e.g. day programs, supported employment).
Licensed meat processing workers
This class is for workers directly involved in the manufacturing and distribution process, where the work is in a cold environment and workers are unable to maintain physical distancing requirements. It does not include retail workers including fishmongers and butchers. tail workers including butcher shops, fishmongers
Abattoir workers, including attending veterinarians
Workers in boning rooms
Cold chain transport workforce
How do I confirm my eligibilty under Phase 1B?
You will need to provide documentation to verify your eligibility under Phase 1B.
If you are an existing Double Bay Doctors patient
We will be able to review your medical history to confirm your health status.
If you are eligible under another category you will need to supply proof of employment, or a letter from your employer.
If you are NOT a Double Bay Doctors patient
You will need to bring a copy of your MyHealth Record/Health Summary, or a letter from your GP confirming your underlying medical condition.
If you are eligible under another category, you will need to supply proof of employment, or a letter from your employer.
What to bring your appointment
Vaccine Dose 1: Please remember to bring:
Your eligibility documentation, if relevant to you. Please refer to How do I confirm my eligibility under Phase 1 B;
Vaccine Dose 2: Please remember to bring:
Looking for more information?
Please visit our comprehensive list of FAQs for more information.
UPDATE: New guidelines for administration of the AstraZeneca vaccine in adults <50years old
Protecting patients is our first priority. We have temporarily suspended appointments for patients under 50yo for the AstraZeneca COVID-19 vaccine as we await further information from Government. Please see below if you are under 50yo and have already received Dose 1 of the AstraZeneca vaccine.
10.00am Monday 12 April 2021
The Australian Technical Advisory Group on Immunisation (ATAGI) has revised its guidelines on the administration of the AstraZeneca vaccine.
AstraZeneca remains the preferred COVID-19 vaccine for adults aged 50 years and over and the Pfizer vaccine is now the preferred vaccine for patients under the age of 50.
The new advice from the ATAGI was not a prohibition on the use of the AstraZeneca vaccine in people aged under 50 and adults under the age of 50 should only be given AstraZeneca where the benefits clearly outweighed the risks. At this stage we continue to accept vaccine clinic bookings for patients under the age of 50 who have underlying health conditions during which they can discuss if the AstraZeneca vaccine is appropriate for them.
Adults under 50 who had already received their first dose of the AstraZeneca vaccine without experiencing serious side effects could safely be given their second dose.
Please note that the risk of severe side effects with the AstraZeneca vaccine continues to be much lower than with common drugs including paracetamol and the oral contraceptive pill.
We await further guidance from Government and will update our patients as soon as we learn more.
We have increased administration resources to manage the Double Bay Doctors COVID-19 vaccination program, but as we currently manage a very high volume of enquiries, we politely discourage patients from calling to cancel their appointment (see below for instructions) or with questions about the vaccine rollout. If you have questions about your eligibility/suitability for the AstraZeneca vaccine, we encourage you book an appointment to discuss your concerns with your GP.
Updated guidelines for administration of the AstraZeneca vaccine in adults <50years old
I am under 50 years old and have received Dose 1 of the AstraZeneca vaccine, without experiencing serious side effects, should I still get a Dose 2 of the Astra Zeneca vaccine?
Yes. The medical recommendation is that adults under 50 who had already received their first doses without experiencing serious side effects could safely be given their second dose.
I do not want to proceed with my appointment for the AstraZeneca vaccine. How can I cancel my appointment?
To cancel your appointment please access, or download, the AMS Connect app (accessible for download for Apple here) and follow the easy prompts to cancel your appointment.
We have increased admin resources to manage the Double Bay Doctors COVID-19 vaccination program, but our team is managing a high level of enquiries, so your support and cooperation is greatly appreciated. We apologise in advance if you have to wait to speak with a receptionist.
Will I be able to get the Pfizer vaccine at my local GP?
We don't know. We have not been supplied with any guidance from Government about whether General Practices will receive the Pfizer vaccine. It's worth noting the Pfizer vaccine must be stored at minus 60C to minus 90C temperatures and to date has been limited to hospital facilities.
When we have more information about how to receive the Pfizer COVID-19 vaccine we will update you.
What is this side effect that everyone is talking about associated with the AstraZeneca vaccine?
There is evidence of a likely link between the AstraZeneca vaccine and an extremely rare blood clotting syndrome (thrombosis with thrombocytopenia).
The recommendation from the Australian Technical Advisory Group on Immunisation (ATAGI) is that use of Comirnaty COVID-19 vaccine (Pfizer) is preferred over AstraZeneca COVID-19 vaccine in adults under 50 years old who have not already had a first dose of the AstraZeneca vaccine.
Is the AstraZeneca vaccine safe?
Yes. The individual benefit-to-risk balance of vaccination with the AstraZeneca COVID-19 vaccine varies with age. This balance is based on factors including the increased risk of complications from COVID-19 with increasing age and the potential lower risk of this very rare, but serious, adverse event with increasing age. ATAGI has recommended the AstraZeneca vaccine remains safe to be given to people aged 50 years and over.
I have had my first dose of the AstraZeneca vaccine, what do I do now?
If you have had your first vaccine dose without this side effect or other serious adverse effects, you should receive your second dose as planned.
What if I am worried about side effects?
If you have recently had your first vaccine dose and are experiencing any side effects that you are worried about, you can book an appointment for you to see your doctor.